Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Product/Service, Conference Call

QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020


QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced it would hold a conference call on Wednesday, October 28, after releasing full results for the third quarter and first nine months of 2020 on Tuesday, October 27.

The call is scheduled for 14:00 Frankfurt time / 13:00 London time / 9:00 New York time. It will be hosted by Thierry Bernard, Chief Executive Officer, and Roland Sackers, Chief Financial Officer. (For Europe: Due to the U.S. time switch, the timing of our investor conference call will be held one hour earlier than usual.)

Conference call and webcast details:

Interested parties may listen to the call by dialing:

+1 929 477 0448 (U.S.)
+44 (0)330 336 9411 (UK)
+49 (0)69 2222 2018 (Germany)

Conference ID: 8213322.

Please join the conference call about 5-10 minutes prior to the start time.

The webcast will be accessible at:
https://globalmeet.webcasts.com/starthere.jsp?ei=1394124&tp_key=2f08733c5b

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1394124&tp_key=2f08733c5b

Contact: [email protected]

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of September 30, 2020, QIAGEN employed more than 5,300 people in over 35 locations worldwide.Further information can be found at http://www.qiagen.com.


These press releases may also interest you

at 23:19
The Industrial Technology Research Institute (ITRI) convened the 2024 ITRI Net Zero Day in Taipei, accelerating industry's transition to net-zero emissions. The event highlighted key innovations and successful business cases, focusing on the...

at 22:33
The report titled "Identity Governance & Administration Market by Component (Services, Solution), Modules (Access Certification & Compliance Control, Access Management, Identity Lifecycle Management), Organization Size, Deployment, Vertical - Global...

at 22:03
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 20:35
Bristow Group Inc. , the global leader in innovative and sustainable vertical flight solutions, today announced it will release its first quarter 2024 financial results and selected financial outlook for 2025 and 2026 after market close on Tuesday,...

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:00
SUNRATE, an intelligent global payment and treasury management platform has been named one of the Top 100 Cross-Border Payment Companies for 2024 by FXC Intelligence, which recognises and celebrates the most important players in the cross-border...



News published on and distributed by: